This project will continue studies of the mechanisms that lead to antigen-specific tolerance of mature CD8 plus T cells in the periphery, focusing on the roles of activation-induced cell death and non- responsiveness. In comparison to CD4 plus cells, relatively little is known about these mechanisms in CD8 plus T cells.
The Specific Aims i nclude:
(Aim 1). To further characterize activation-induced anergy and death in CD8 plus T cells in vitro. Experiments will be done to test two hypothesis: (I) Induction of non-responsiveness in CD8 plus T cells following an initial response to antigen depends upon the nature of the primary costimulatory ligands (B7 versus ICAM-1) and (ii) The balance of death and anergy following response of CD8 plus cells to antigen depends upon the quantitative """"""""strength"""""""" and duration of the initial signals (antigen dose/duration, costimulatory ligand density, etc).
(Aim 2) To determine the mechanisms of in vitro induction of anergy and death in CD8 T cells. Responses to B7 and ICAM-1 costimulatory ligands will be further examined to determine the expression and roles of Bcl-xL and Bcl-2 survival proteins, the role of CTLA-4 in induction of death and non-responsiveness, and the roles of Fas/Fas-L and TNF-alpha in apoptotic death.
(Aim 3) To define the requirements for in vivo induction of activation -induced anergy and death in CD8 T cells. An adoptive transfer system has been established for studying the responses of CD8 plus cells from TCR transgenic mice that allows that number, locations and phenotype of the cells to be determined during the course of an in vivo response. Predictions made by the in vitro studies under Aims 1 and 2 will be tested in vivo using microspheres having well defined antigen and costimulatory ligand compositions as """"""""artificial APCs"""""""". Results obtained in this project studying mature CD8 plus T cells will complement those obtained in the other Program projects examining similar issues in CD4 plus cells, and class I restricted thymocytes.

Project Start
2000-09-01
Project End
2001-08-31
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
8
Fiscal Year
2000
Total Cost
$110,508
Indirect Cost
Name
University of Minnesota Twin Cities
Department
Type
DUNS #
168559177
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Burrack, Adam L; Malhotra, Deepali; Dileepan, Thamotharampillai et al. (2018) Cutting Edge: Allograft Rejection Is Associated with Weak T Cell Responses to Many Different Graft Leukocyte-Derived Peptides. J Immunol 200:477-482
Breed, Elise R; Lee, S Thera; Hogquist, Kristin A (2018) Directing T cell fate: How thymic antigen presenting cells coordinate thymocyte selection. Semin Cell Dev Biol 84:2-10
Osum, Kevin C; Burrack, Adam L; Martinov, Tijana et al. (2018) Interferon-gamma drives programmed death-ligand 1 expression on islet ? cells to limit T cell function during autoimmune diabetes. Sci Rep 8:8295
Ruscher, Roland; Hogquist, Kristin A (2018) Intravenous Labeling and Analysis of the Content of Thymic Perivascular Spaces. Bio Protoc 8:
Kotov, Dmitri I; Kotov, Jessica A; Goldberg, Michael F et al. (2018) Many Th Cell Subsets Have Fas Ligand-Dependent Cytotoxic Potential. J Immunol 200:2004-2012
Schuldt, Nathaniel J; Auger, Jennifer L; Spanier, Justin A et al. (2017) Cutting Edge: Dual TCR? Expression Poses an Autoimmune Hazard by Limiting Regulatory T Cell Generation. J Immunol 199:33-38
Kalekar, Lokesh A; Mueller, Daniel L (2017) Relationship between CD4 Regulatory T Cells and Anergy In Vivo. J Immunol 198:2527-2533
Burrack, Adam L; Martinov, Tijana; Fife, Brian T (2017) T Cell-Mediated Beta Cell Destruction: Autoimmunity and Alloimmunity in the Context of Type 1 Diabetes. Front Endocrinol (Lausanne) 8:343
Ruscher, Roland; Kummer, Rebecca L; Lee, You Jeong et al. (2017) CD8?? intraepithelial lymphocytes arise from two main thymic precursors. Nat Immunol 18:771-779
Schmiel, Shirdi E; Yang, Jessica A; Jenkins, Marc K et al. (2017) Cutting Edge: Adenosine A2a Receptor Signals Inhibit Germinal Center T Follicular Helper Cell Differentiation during the Primary Response to Vaccination. J Immunol 198:623-628

Showing the most recent 10 out of 136 publications